← Back to Search

Procedure

Harmonic Scalpel vs Electrocautery for Lung Cancer

N/A

Recruiting

Led By Joseph Newton, MD

Research Sponsored by Sentara Cardiovascular Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients undergoing resection for stage 1, 2 or 3A lung cancer

Patients between the ages of 20-75

Timeline

Screening 3 weeks

Treatment Varies

Follow Up every other day and at four weeks

Awards & highlights

Study Summary

This trial will compare the Harmonic Scalpel to a control group using electrocautery in order to determine which is more effective in minimizing drainage and length of stay.

Who is the study for?

This trial is for people aged 20-75 who are having lung cancer surgery (stage 1, 2 or 3A) and have not joined another study. It's not for those with kidney failure, heart failure, pregnant individuals, or stage 3A patients with bulky lymph nodes.Check my eligibility

What is being tested?

The study compares the Harmonic Scalpel to electrocautery in lung cancer surgery. The goal is to see if the Harmonic Scalpel can better seal lymphatics to reduce drainage and potentially shorten hospital stays.See study design

What are the potential side effects?

Potential side effects may include issues related to surgical procedures such as infection risk at the incision site, bleeding, pain or discomfort post-operation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My lung cancer is at an early to mid-stage (1, 2, or 3A) and I am having surgery to remove it.

Select...

I am between 20 and 75 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ daily

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~daily

This trial's timeline: 3 weeks for screening, Varies for treatment, and daily for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Amount of chest tube drainage

Secondary outcome measures

Pleural effusions monitored by chest x-ray.

Trial Design

2Treatment groups

Active Control

Group I: Group AActive Control1 Intervention

Electrocautery used for dissection.

Group II: Group BActive Control1 Intervention

Harmonic Scalpel used for dissection

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Sentara Cardiovascular Research InstituteLead Sponsor

Ethicon Endo-SurgeryIndustry Sponsor

83 Previous Clinical Trials

35,760 Total Patients Enrolled

Joseph Newton, MDPrincipal InvestigatorSentara Cardiovascular Research Institute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who fulfills the criteria to enter this clinical trial?

"This medical trial requires participants aged between 20 and 75 that are suffering from lung cancer. The recruitment of 50 patients is needed to complete the study."

Answered by AI

Are there any openings left for potential participants in this experiment?

"Per clinicaltrials.gov, this research initiative is currently accepting participants. The trial was first advertised on December 1st 2007 and had its most recent update on October 25th 2022."

Answered by AI

What is the total number of participants being enrolled in this experiment?

"Affirmative. Clinicaltrials.gov attests that this research project, which was first advertised on December 1st 2007, is currently seeking volunteers. Approximately 50 participants are required from a single clinical trial site."

Answered by AI

Is the minimum age requirement for this research study below 70 years?

"This clinical trial only admits patients aged between 20 and 75 years old. There are 44 studies for minors, while those over the age of 65 can select from 1,624 trials to participate in."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Use of Harmonic Scalpel to Decrease Lymphatic and Chest Tube Drainage After Lymph Node Dissection With Lobectomy.

2007. "Use of Harmonic Scalpel to Decrease Lymphatic and Chest Tube Drainage After Lymph Node Dissection With Lobectomy.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00591552.

All > Virginia